Postoperative radiotherapy for advanced medullary thyroid cancer - local disease control in the modern era

Head and Neck

Volumn 30, Issue 7, 2008, Pages 883-888

  Schwartz, David L ^a   Rana, Vishal ^a   Shaw, Stephanie ^a   Yazbeck, Cynthia ^a   Ang, Kie Kian ^a   Morrison, William H ^a   Rosenthal, David I ^a   Hoff, Ana ^a   Evans, Douglas B ^a   Clayman, Gary L ^a   Garden, Adam S ^a   Sherman, Steven I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Adjuvant; IMRT; Medullary thyroid carcinoma; Outcomes; Postoperative; Radiotherapy

Indexed keywords

CALCITONIN;

ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE CONTROL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KAPLAN MEIER METHOD; MALE; MORBIDITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL RATE; SURVIVAL TIME; THYROID MEDULLARY CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; BRACHYTHERAPY; CARCINOMA, MEDULLARY; COHORT STUDIES; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHANTOMS, IMAGING; POSTOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 47549104319     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20791     Document Type: Article

References (18)

1. Quayle FJ, Moley JF. Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes. J Surg Oncol 2005;89:122-129.
2. Kouvaraki MA, Shapiro SE, Perrier ND, et al. RET proto-oncogene: a review and update of genotype-pheno-type correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid 2005;15:531-544.
3. Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 1999; 229:880-887; discussion 887-888.
4. Cohen MS, Moley JF. Surgical treatment of medullary thyroid carcinoma. J Intern Med 2003;253:616-626.
5. Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB. Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. Surgery 2003;134:890-899; discussion 899-901.
6. Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 2000;89:202-217.
7. Brierley J, Tsang R, Simpson WJ, Gospodarowicz M, Sutcliffe S, Panzarella T. Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 1996;6:305-310.
8. Fife KM, Bower M, Harmer CL. Medullary thyroid cancer: the role of radiotherapy in local control. Eur J Surg Oncol 1996;22:588-591.
9. Peixoto Callejo I, Americo Brito J, Zagalo CM, Rosa Santos J. Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival. Clin Transl Oncol 2006,8:435-443.
10. Chow SM, Chan JK, Tiu SC, Choi KL, Tang DL, Law SC. Medullary thyroid carcinoma in Hong Kong Chinese patients. Hong Kong Med J 2005;11:251-258.
11. Esik O, Tusnady G, Tron L, et al. Markov model-based estimation of individual survival probability for medullary thyroid cancer patients. Pathol Oncol Res 2002;8:93-104.
12. Williams CR, Brewer DB. Medullary carcinoma of the thyroid. Br J Surg 1969;56:437-443.
13. Samaan NA, Schultz PN, Hickey RC. Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. J Clin Endocrinol Metab 1988;67:801-805.
14. Tubiana M, Lacour J, Monnier JP, et al. External radiotherapy and radioiodine in the treatment of 359 thyroid cancers. Br J Radiol 1975;48:894-907.
15. Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D. External radiotherapy in thyroid cancers. Cancer 1985;55(9, Suppl):2062-2071.
16. Rosenbluth BD, Serrano V, Happersett L, et al. Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. Int J Radiat Oncol Biol Phys 2005;63:1419-1426.
17. Drosten M, Putzer BM. Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy. Nat Clin Pract Oncol 2006;3:564-574.
18. Moley JF, Fialkowski EA. Evidence-based Approach to the Management of Sporadic Medullary Thyroid Carcinoma. World J Surg 2007;31:946-956.